ClinConnect ClinConnect Logo
Search / Trial NCT06109844

FORCEREPAIR - A Wound Exudate Investigation

Launched by BISPEBJERG HOSPITAL · Oct 26, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Venous Leg Ulcer Varicose Ulcer Cytokines Wound Exudate Wound Healing Wound Inflammation Wound Microbiome

ClinConnect Summary

The FORCEREPAIR trial is an important study looking at how wounds, specifically venous leg ulcers, heal over time. Researchers will collect samples of the fluid that comes from these wounds, known as wound exudate, from twenty adults who have been diagnosed with venous leg ulcers. By examining these samples and monitoring the size of the wounds during four visits, the study aims to understand the healing process better and how bacteria might affect it.

To participate, you need to be an adult over 18 years old with a confirmed diagnosis of a venous leg ulcer that meets specific characteristics, such as swelling and discoloration. You also need to be able to understand Danish and agree to follow the study protocol. If you join the study, you can expect to visit the research site several times for evaluations and sample collections, which will help researchers gain valuable insights into wound healing. It's important to note that certain conditions, like having a wound that goes down to the bone or known cancer in the wound, may prevent someone from participating.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults fulfilling all inclusion criteria
  • Age \>18 years
  • Venous leg ulcer diagnosis and classic characteristics (localisation, varicose veins, brown-orange hyperpigmentation, leg oedema, stasis dermatitis, atrophie blanche or lipodermatosclerosis) verified by a wound expert (if in doubt venous doppler will be used for verification)
  • Wound Area equal to or above 1 cm2 (measured with a ruler length x width)
  • Patient can understand Danish
  • Patient can comply with protocol
  • Patient is fully informed about the study and has given informed consent
  • Exclusion Criteria:
  • Venous leg ulcer with communication to bone
  • Known or suspected cancer in the wound
  • Allergies towards products used in the study, e.g. polyurethane foam and tegaderm
  • Dementia
  • Judgement by the investigator that the patient is not suited for study participation

About Bispebjerg Hospital

Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.

Locations

Copenhagen, Northwest, Denmark

Viborg, , Denmark

Patients applied

0 patients applied

Trial Officials

Frederik Plum, MD

Principal Investigator

Bispebjerg Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported